Changeflow GovPing Pharma & Drug Safety FORSYNTH Trademark Application - Intent to Use
Routine Notice Added Final

FORSYNTH Trademark Application - Intent to Use

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application (TM99497965) for the mark FORSYNTH. The application covers goods and services including dietary supplements, probiotic supplements, and related laboratory research services.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO has recorded an intent-to-use trademark application for the mark FORSYNTH, filed on November 14, 2025. The application, identified as TM99497965, seeks protection for a range of products and services, including dietary supplements for humans and pets, nutritional supplements for animals, and laboratory research services related to pharmaceuticals. This filing indicates a potential future commercial use of the FORSYNTH mark in these sectors.

While this is a trademark filing and not a regulatory rule, companies operating in the pharmaceutical and supplement space should be aware of new brand applications. Compliance officers should monitor for potential conflicts with existing brands or product lines. No immediate compliance actions are required based on this filing, but it may inform future branding and marketing strategies.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

FORSYNTH

Intent to Use TM99497965 Kind: intenttouse Mar 22, 2026

Abstract

Dietary supplements; Probiotic supplements; Dietary supplements for pets; Nutritional supplements for animals; Laboratory research services relating to pharmaceuticals; Scientific research and development; Technical consultancy in the field of scientific research

Filing Date

2025-11-14

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
November 14th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99497965

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademarks
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Trademarks Dietary Supplements

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!